LONDON--(BUSINESS WIRE)--The global human microbiome therapeutics market is expected to grow at a CAGR of more than 14% from 2018-2022, according to a new market research report by Technavio.
Global human microbiome therapeutics market segmentation by therapeutic application and geography
Technavio’s report on the global human microbiome therapeutics market analyses the business dimensions and presents a comprehensive breakdown in terms of market segmentation by therapeutic application, including gastrointestinal disorders and immunological conditions. As projected in 2017, around 66% of the market share originated from gastrointestinal disorders.
Based on geography, the global human microbiome therapeutics market has been segmented into APAC, EMEA, and the Americas. As of 2017, almost 45% of the market share came from the Americas.
“The human microbiome therapeutics market in the Americas is anticipated to experience significant growth. Factors such as substantial investments in R&D for the development of novel therapeutic techniques and high incidences of gastrointestinal and metabolic disorders and immunological disorders drive the market in the region,” says a senior analyst at Technavio for cardiovascular and metabolic disorders research.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Global human microbiome therapeutics market: competitive landscape
Many of the products are in the clinical stage of development and are performed by specialist companies dealing in the niche market. Major R&D performers in the field are either research institutes or academic institutions. These are attractive products present in the pipeline for the global microbiome therapeutics and will lead to change in the competitive scenario during the forecast period.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Other topics covered in the report:
Market drivers:
- Growing prevalence of chronic diseases
- Side effects of existing treatment
Market trends:
- Increase in industry-academia collaboration
- Increasing investments by venture capitalists
Get a sample copy of the global human microbiome therapeutics market report free of cost
Access Technavio’s continuously growing cardiovascular and metabolic disorders research library and find expert analysis on hundreds of markets.
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
